Champions Oncology, Inc. (CSBR)

NASDAQ: CSBR · Real-Time Price · USD

5.96

+0.10 (1.71%)

At close: Mar 23, 2026, 4:00 PM EDT

5.96

0.00 (0.00%)

After-hours: Mar 23, 2026, 4:00 PM EDT

Champions Oncology Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Revenue	57.95	56.94	50.16	53.87	49.11	41.04
Revenue Growth (YoY)	-1.10%	13.54%	-6.90%	9.70%	19.66%	27.76%
Cost of Revenue	31.36	28.39	29.4	29.53	23.63	21.45
Gross Profit	26.58	28.56	20.75	24.34	25.48	19.59
Selling, General & Admin	19.87	16.88	18.13	17.24	15.5	12.03
Research & Development	8.93	6.83	9.54	11.55	9.37	7.2
Other Operating Expenses	0.4	0.29	0.44	0.81	-	-
Total Operating Expenses	29.21	24	28.11	29.59	24.87	19.23
Operating Income	-2.63	4.55	-7.36	-5.26	0.61	0.37
Total Non-Operating Income (Expense)	0.23	0.07	0.05	-0.01	-0.02	0.07
Pretax Income	-2.4	4.63	-7.31	-5.27	0.58	0.44
Provision for Income Taxes	0.07	-0.08	-0.03	0.07	0.04	0.08
Net Income	-2.31	4.7	-7.28	-5.34	0.55	0.36
Minority Interest in Earnings	-0.03	-	-	-	-	-
Net Income to Common	-2.31	4.7	-7.28	-5.34	0.55	0.36
Net Income Growth	-	-	-	-	51.38%	-
Shares Outstanding (Basic)	14	14	14	14	13	13
Shares Outstanding (Diluted)	14	14	14	14	14	15
Shares Change (YoY)	-0.24%	5.31%	0.04%	-4.37%	-2.84%	23.05%
EPS (Basic)	-0.16	0.34	-0.54	-0.39	0.04	0.03
EPS (Diluted)	-0.16	0.33	-0.54	-0.39	0.04	0.02
EPS Growth	-	-	-	-	100.00%	-
Free Cash Flow	-	7	-6.97	1.1	4.11	-4.96
Free Cash Flow Growth	-	-	-	-73.26%	-	-
Free Cash Flow Per Share	-	0.49	-0.51	0.08	0.29	-0.34
Gross Margin	45.88%	50.15%	41.38%	45.18%	51.88%	47.74%
Operating Margin	-4.53%	8.00%	-14.67%	-9.76%	1.24%	0.89%
Profit Margin	-4.04%	8.26%	-14.51%	-9.90%	1.12%	0.88%
FCF Margin	-	12.29%	-13.90%	2.04%	8.38%	-12.09%
EBITDA	-2.63	6.19	-5.49	-3.01	2.23	1.55
EBITDA Margin	-4.53%	10.88%	-10.94%	-5.59%	4.55%	3.78%
EBIT	-2.63	4.55	-7.36	-5.26	0.61	0.37
EBIT Margin	-4.53%	8.00%	-14.67%	-9.76%	1.24%	0.89%
Effective Tax Rate	-3.08%	-1.62%	0.44%	-1.29%	6.00%	17.16%

Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q